EPTFE Breathable Vent For Closed System Transfer Device Vial Access

Product Overview

The ePTFE breathable vent for Closed System Transfer Device (CSTD) medication vial access is a high-precision, chemically resistant sterile barrier component engineered specifically for the safe handling of hazardous pharmaceutical substances. This vent integrates a low-extractable, chemically inert ePTFE membrane with a weldable or mechanically sealable carrier, designed for integration into the pressure equalization pathway of CSTD vial adaptors, syringe connectors, and bag spikes. During the reconstitution and withdrawal of cytotoxic, antineoplastic, and other hazardous medications from sealed vials, the vent provides a sterile, filtered airflow that equalizes the vial's internal pressure without releasing toxic medication aerosols, vapors, or droplets into the pharmacy or clinical environment. It protects pharmacists, nurses, and compounding technicians from occupational exposure to carcinogenic, teratogenic, and irritant agents, while maintaining the sterility of the injectable product. This vent is a critical enabling component for compliance with USP <800> (Hazardous Drugs—Handling in Healthcare Settings) and NIOSH guidelines.

Cause

Cytotoxic and other hazardous medications are prepared in hospital pharmacies and oncology compounding centers. These medications are typically supplied as a lyophilized powder or concentrated solution in a sealed glass vial. To prepare a patient dose, a pharmacist must inject a diluent into the vial, dissolve or mix the medication, and withdraw the required volume. Each time fluid is added or removed, the pressure inside the vial changes. Without pressure equalization, a vacuum will form that makes it impossible to withdraw the full dose, or positive pressure will develop that causes the medication to spray out when the syringe is disconnected—a phenomenon known as "vial aerosolization." This aerosolization creates an invisible cloud of potent medication particles that the operator can inhale or that can settle on surfaces and skin. Chronic low-level exposure to hazardous medications has been linked to reproductive toxicity, genetic damage, and increased cancer risk in healthcare workers. A CSTD is mandated to mechanically prevent this contamination. The CSTD's vent must allow clean air into the vial to replace the withdrawn liquid, but it must absolutely prevent the escape of the medication aerosol and must be chemically resistant to the aggressive solvents (e.g., dimethyl sulfoxide, N-methyl-2-pyrrolidone, polysorbates) used in injectable medication formulations.

Solution

The ePTFE breathable vent is integrated into the CSTD vial adaptor's airway. When the pharmacist withdraws the medication solution, the pressure in the vial drops. Ambient air is drawn through the vent's 0.2-micron ePTFE membrane into the vial, instantly equalizing pressure. The membrane is an absolute barrier to the medication aerosol and droplets; its hydrophobic and oleophobic treatment prevents liquid wetting, and its particle retention efficiency (≥ 99.97% at 0.3 μm) captures the medication particles. The chemically inert ePTFE withstands the aggressive solvents and surfactants in injectable medication formulations without swelling, degrading, or leaching. The membrane maintains a sterile barrier, preventing bacterial contamination from entering the vial during the compounding process. The vent enables smooth, continuous operation, allowing the full dose to be withdrawn without the vial "fighting back" and without any hazardous aerosol release.

Specifications
Parameter Specification
Product Type ePTFE Breathable Vent for CSTD
Membrane Material Low-extractable, chemically inert ePTFE
Pore Size 0.2 μm (sterilizing-grade)
Particle Retention ≥ 99.97% at 0.3 μm (HEPA-equivalent, medication aerosol capture)
Biological Barrier Bacterial and viral retention per ASTM F838, F1671
Airflow 100-500 ml/min @ 1 psi
Water Entry Pressure ≥ 100 kPa
Chemical Resistance DMSO, NMP, polysorbates, ethanol, propylene glycol, common injectable solvents
Carrier Material PP, PE, or medical-grade adhesive
Sterilization Gamma, EtO
Regulatory Support USP <800>, NIOSH compliant; ISO 10993 biocompatible
Application

CSTD vial adaptor pressure equalization vents

CSTD syringe connector and injector vents

Hazardous medication compounding robot tubing and syringe vents

Chemotherapy preparation isolator and BSC vent ports

Radiopharmaceutical preparation vial vents

Gene therapy vector preparation vial vents

How It Works

The vent is integrated into the airway of the CSTD vial adaptor. The adaptor is snapped onto the medication vial, and a syringe with diluent is attached. As the pharmacist pushes diluent into the vial, the displaced air vents out through the CSTD's exhaust filter. When the pharmacist pulls back on the syringe plunger to withdraw the medication solution, a vacuum forms. Clean ambient air is pulled through the ePTFE vent membrane into the vial, replacing the withdrawn liquid volume and eliminating the vacuum. The 0.2-micron membrane physically blocks any medication particles or aerosols from escaping. The chemically resistant ePTFE is unaffected by the medication formulation's solvents and surfactants. The entire process is sealed and contained, protecting the operator and maintaining sterility.

How To Choose

Identify the medication formulations to be handled and their solvent systems to confirm ePTFE and carrier chemical compatibility.

Determine the CSTD adaptor design and the available space for the vent integration.

Select the vent format: a weldable carrier for permanent integration into the adaptor, or an adhesive format for simpler assembly.

Validate the complete CSTD system: aerosol containment testing (e.g., using fluorescein or surrogate tracer), bacterial challenge, and chemical compatibility soak testing.

Ensure the vent and CSTD meet the "no escape" aerosol test criteria defined by NIOSH and USP <800>.

FAQ

Q: Can the vent resist the aggressive solvents used to dissolve lyophilized oncology medications?
A: Yes, ePTFE is one of the most chemically inert materials available. It withstands dimethyl sulfoxide, NMP, and other aggressive injectable excipients. We provide chemical compatibility data for common hazardous medication formulations.

Q: Does the vent prevent the release of volatile chemotherapy medication vapors?
A: The membrane captures liquid aerosols and particles. Volatile vapor molecules may pass through as individual gas molecules; for volatile hazardous medications, the CSTD system should include a vapor-capable carbon filter stage in addition to the particulate vent.

Q: Can the vent be pre-sterilized and integrated into a single-use disposable CSTD?
A: Yes, we supply gamma-sterilized vents in validated sterile packaging for integration into single-use CSTD devices.

Q: What is the flow rate of the vent, and does it slow down the compounding process?
A: The vent's airflow is sized to support the typical syringe draw rates used in chemotherapy compounding, so the pressure equalization is instantaneous and does not slow workflow.

Q: Is the vent integrity tested to ensure no medication aerosol escapes?
A: We recommend a post-assembly pressure decay or aerosol challenge test of the completed CSTD device to verify the vent's integrity and seal.